Highlights and Quick Summary
- Issuance/Purchase of Shares for the quarter ending December 31, 2022 was $-200 Thousand (a -Infinity% decrease compared to previous quarter)
- Year-over-year quarterly Issuance/Purchase of Shares decreased by -99.65%
- Annual Issuance/Purchase of Shares for 2022 was $-82.1 Million (a -22.55% decrease from previous year)
- Annual Issuance/Purchase of Shares for 2021 was $-106 Million (a -1392.68% decrease from previous year)
- Annual Issuance/Purchase of Shares for 2019 was $8.2 Million (a -8300.0% decrease from previous year)
- Twelve month Issuance/Purchase of Shares ending December 31, 2022 was $-82.1 Million (a -56.31% decrease compared to previous quarter)
- Twelve month trailing Issuance/Purchase of Shares decreased by -43.03% year-over-year
Trailing Issuance/Purchase of Shares for the last four month:
| 31 Dec '22 | 30 Sep '22 | 30 Jun '22 | 31 Mar '22 |
|---|---|---|---|
| $-82.1 Million | $-188 Million | $-175 Million | $-144 Million |
Visit stockrow.com/EBS
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Issuance/Purchase of Shares of Emergent Biosolutions Inc.
Most recent Issuance/Purchase of Sharesof EBS including historical data for past 10 years.Interactive Chart of Issuance/Purchase of Shares of Emergent Biosolutions Inc.
Emergent Biosolutions Inc. Issuance/Purchase of Shares for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | $-0.2 | $0.0 | $-24.4 | $-57.5 | $-82.1 |
| 2021 | – | $-106.0 | $12.5 | $6.9 | $-106.0 |
| 2020 | – | $26.6 | $23.1 | $9.1 | – |
| 2019 | $2.5 | $1.1 | $3.7 | $0.9 | $8.2 |
| 2018 | $-11.4 | $2.9 | $3.8 | $4.6 | $-0.1 |
| 2017 | $-24.52 | $6.19 | $1.65 | $2.88 | $-13.8 |
| 2016 | $2.12 | $0.46 | $10.93 | $3.6 | $17.1 |
| 2015 | $9.96 | $2.74 | $6.82 | $6.34 | $25.86 |
| 2014 | $3.22 | $0.69 | $1.83 | $8.14 | $13.88 |
| 2013 | $4.13 | $1.57 | $0.43 | $0.5 | $6.64 |
| 2012 | $-4.18 | – | – | – | $-5.15 |
Business Profile of Emergent Biosolutions Inc.
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic